Article info

Download PDFPDF

Correspondence on ‘Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort’ by Micheroli et al
Free

Authors

  • Jin-Xian Huang Department of Rheumatology, University of Hong Kong-Shenzhen Hospital, Shenzhen, China PubMed articlesGoogle scholar articles
  • Pui-Ying Leong Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, TaiwanInstitute of Medicine, Chung Shan Medical University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • James Cheng-Chung Wei Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, TaiwanInstitute of Medicine, Chung Shan Medical University, Taichung, TaiwanGraduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr James Cheng-Chung Wei, Institute of Medicine, Chung Shan Medical University, Taichung 404, Taiwan; jccwei{at}gmail.com
View Full Text

Citation

Huang J, Leong P, Wei JC
Correspondence on ‘Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort’ by Micheroli et al

Publication history

  • Received August 3, 2020
  • Revised August 7, 2020
  • Accepted August 8, 2020
  • First published September 15, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.